Cellular targeting is one way to actively target solely diseased tissue in the body is to know the nature of a receptor on the cell for which the drug will be targeted and then utilization of cell-specific ligands will allow the nanoparticle to bind specifically to the cell that has the complementary receptor.
Intracellular delivery enables efficient drug delivery into various types of cells and it is a long-term studied topic in modern biotechnology. It is a critical process in many cellular-level studies, such as cellular drug therapy, gene editing delivery, and a series of biomedical research applications.
Targeted Drug Delivery System:A targeted drug delivery system is a particular form of drug delivery where the drug is released specifically to its site of action and not to the target organs, tissues, or cells.
Drug Targeting and Design: Drug targeting can be defined as the ability of a drug molecule to accumulate in the target organ or tissue specifically, so that the concentration of the drug will be high at the disease, while in non-target organs and tissues, its concentration is low, preferably, below the certain minimal level so as to prevent any toxic effects. Drug targeting can control the non-specific toxic effect of conventional drug delivery.
Drug design is also known as rational drug design or simply rational design. It is a new process of producing new medications based on the knowledge of a biological target.
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami, United States
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, University of Alberta, Canada
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N D Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : R&D consultancy at the medicines discovery catapult: De-risking drug discovery for innovators
Adriana Gambardella, Medicine Discovery Catapult, United Kingdom
Title : Biocompatible synthesis of non crystalline iron oxide nanoparticles with stable colloidal properties
Lan Wang, Paretor LLC, United States
Title : Precision diagnostics: Effectiveness of innovative imaging technologies for early detection of lung cancers
Huiqin Yang, ICON Clinical Research Ltd, United Kingdom
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Design and characterization of gum arabic buccal films for protein drug delivery
Krisztian Pamlenyi, University of Szeged, Hungary
Title : Advancing EGFR-targeting macrocyclic peptide-drug conjugates to target KRAS-mutant solid tumors: Design, synthesis, and preclinical evaluations
Akash Panja, Ariel University, Israel